Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Hepalatide by Shanghai HEP Pharmaceutical for Hepatitis D: Likelihood of Approval
Hepalatide is under clinical development by Shanghai HEP Pharmaceutical and currently in Phase II for Hepatitis D. According to GlobalData,...
Data Insights
Hepalatide by Shanghai HEP Pharmaceutical for Hepatitis B: Likelihood of Approval
Hepalatide is under clinical development by Shanghai HEP Pharmaceutical and currently in Phase II for Hepatitis B. According to GlobalData,...